The Wobenzym Story by Aftab Ahmed, Ph.D
DApproximately 50 years ago, Drs. Max Wolf and Helen Benitez began a journey to find a natural, wholesome, alternative treatment for cancer that would be gentler and less traumatic to the body’s systems than chemotherapy and radiation. When dealing with disease, the human body produces proteins that can be dangerous and further enhance poor health. However, one of the most beneficial classes of enzymes is called proteolytic enzymes and they have the ability to break down proteins into smaller chains of amino acids. Drs. Wolf and Benitez theorized that the use of proteolytic enzymes might help to eat up the dangerous proteins being produced when some is struggling with disease and improve the persons overall health while fighting off that disease. While the doctors were hopeful for success in finding a natural “cure” for cancer, they could not have known all the numerous health benefits they would reveal during their study of enzymes.
Drs. Wolf and Benitez, along with another researcher from Germany named Dr. Karl Ransberger, evaluated a large number of enzymes derived from plant and animal sources. The researchers began inspecting the interaction of different enzymes combined to see what beneficial effects could be achieved with different combinations. Finally, a combination of systemic enzymes coordinated to produce a variety of health applications and Wobenzym was born. The Wobenzyme is a brand of formulated proteolytic enzymes
Dr Ransberger decided to develop his systemic enzyme solution into a product that could serve the health needs of people around the world. He joined with his mentor, Dr. Wolf, to create a business partnership and the two moved back to Germany to continue their work in enzyme research and product development. This special enzyme preparation was named, WoBeEnzym, in recognition of Dr. Wolf and Dr. Benitez’ earlier work with systemic enzymes. Wobenzym is a product of MUCOS Pharma and has become recognized worldwide due to the company’s subsidiaries in the United States, Argentina, Mexico, Spain, Czech Republic, India, Pakistan, Korea, and New Zealand. Dr. Ransberger worked tirelessly to develop manufacturing processes that would preserve the enzymes’ full biological activity. He worked with MUCOS Pharma to patent innovative technology that would not only allow proper extraction of the enzymes, but also the stabilized manufacturing into tablet form of the enzymes in a way that maintained maximum benefits and purity. Wobenzym is a state-of-the-art preparation of proteolytic enzymes that is specifically designed to offer ultimate health benefits and promote the enhanced function of the body’s organs, cells, tissues, and chemical reactions.
As mentioned earlier, the enzymes in Wobenzym work to support healthy function of the entire human body. Every chemical reaction and digestive process relies on a healthy supply of enzymes. Specifically, Wobenzym works so effectively to promote health because it contains proteolytic enzymes, which cling to other proteins and can break them down when necessary. The proteolytic enzymes found in Wobenzym help the body maintain homeostasis when healthy, but also helps to fight damaging proteins when diseased. There are multiple clinical trials that have indicated Wobenzym’s ability to minify harmful immune complexes that can lead to autoimmune disorders. In conjunction, immune complexes can precipitate a multitude of diseases because they have been identified for their role in thickening blood.
Even though Drs. Wolf, Benitez, and Ransberger did not find the unequivocal cure for cancer at this point, the proteolytic enzymes in Wobenzym have been found to be very effective in helping to treat some cancers. The sister product, Wobe-Mugos, to Wobenzym by MUCOS is under consideration by the FDA for Orphan Drug status as a contributory treatment for patients with the cancer involving B cells in the blood called multiple myeloma. There is also research being performed to show that proteolytic enzymes found in Wobenzym can aid in the management of pancreatic cancer. Research is continuously being performed concerning proteolytic enzymes and Wobenzym as therapy options for certain cancers.